European Aquaculture Vaccines Market revenue to cross $170 Mn by 2027

Published Date: 2021-03-09

Request a sample

European Aquaculture Vaccines Market size is poised to reach USD 170.3 million by 2027,according to a latest forecast report by Graphical Research.

Surging prevalence of bacterial and viral infections is the major driving factor of the market revenue. Infectious disease is one of the most vital limiting factors in aquaculture. For most warmwater aquaculture facilities, disease prevention consists of good husbandry techniques. When disease outbreak occurs, diagnostics are conducted to determine the actual cause and then the fish are given oral treatment that is an immersion or in rare cases injection treatment. This leads to huge losses both in terms of yield and economic. Thus, to limit the economic losses, the use of vaccines is increasing across the region. 

Development and launch of new aquaculture vaccines will drive the aquaculture vaccines market. Bactrians are vaccines comprised of killed forms of pathogenic bacteria. Live attenuated vaccines consist of live micro-organisms that have been grown in culture. There are different kind of vaccine that are being developed and launched for better aquaculture farming resulting into better production of aquaculture. Also, companies are investing in R&D programs for innovating vaccines.

Live aquaculture vaccines market size was more than USD 17.7 million in 2020. Live vaccines are quite effective and retain attributes of natural infection. In commercial application, live vaccines have greater potential to be administered via immersion or oral routes. Live vaccine mode of administration is more dynamic compared to inactivated vaccines that must utilize adjuvants.

Immersion vaccines segment is predicted to register a growth of over 6.9% from 2021 to 2027. Immersion vaccines are used for variety of aquaculture fish for preventing infectious diseases caused by viruses and bacteria. During immersion vaccination, the antigens are taken up by the gills, gut or skin and processed by the immune system where the response results in protection of fish. Administration of vaccines also depends on the size of fish and in many cases, immersion vaccination is mostly preferred as compared to injection vaccination to achieve optimum protection.

Browse detailed statistical insights from the report, “Europe Aquaculture Vaccines Market Size By Route of Administration (Immersion Vaccines, Injection Vaccines, Oral Vaccines), By Type (Inactivated Vaccines, Live Vaccines), By Application (Bacterial Infection, Viral Infection), By Species (Salmon, Trout, Tilapia), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Belgium, Netherlands, Poland, Portugal, Russia, Sweden, Switzerland, Turkey, Norway, Ireland, Denmark, Greece, Finland), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027” along with the table of contents (ToC) @

Viral infection segment revenue is expected to reach USD 27.4 million by 2027. In aquaculture both wild aquatic and farmed animals in the same water column experience the same viral challenges. Expanding global trade and burgeoning international aquaculture expansion and their products have been accomplished by long distance geographical redistribution of aquatic species and their viruses.

The tilapia segment accounted for USD 2 million revenue in 2020. There are about 70 species of tilapias out of that 9 species are used in aquaculture globally. Tilapias are infected by bacteria and viruses that are to be cured using vaccines. Also, ban on sales of antibiotics for aquaculture will augment the segment growth.

The UK aquaculture vaccines market is estimated to expand at over 6.3% CAGR till 2027. This growth is due to factors such as increasing awareness about various benefits of aquaculture vaccines, new vaccine launches, and growing aquaculture farming. The rapid prevalence of diseases among the fishes will increases the demand of aquaculture vaccination among fishes in the country.  

Major market players are Zoetis Inc., HIPRA, Merck & Co., Inc., Tecnovax, Veterquimica S.A., and Virbac.  among others. These market players focusing on various business strategies such as collaboration, geographic expansion to strengthen their market position. For instance, in in 2018, Phibro Animal Health Corporation acquired Kovax Ltd that is a maker of vaccines.

European aquaculture vaccines market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

Europe Market, By Type of Vaccine, 2016-2027 (USD Million)

  • Inactivated vaccine
  • Live vaccine
  • Others

Europe Market, By Route of Administration, 2016-2027 (USD Million)

  • Immersion vaccines
  • Injection vaccines
  • Oral vaccines

Europe Market, By Application, 2016-2027 (USD Million)

  • Bacterial infection
  • Viral infection
  • Others

Europe Market, By Species, 2016-2027 (USD Million)

  • Salmon
  • Trout
  • Tilapia
  • Others

 The above information has been provided for the following countries:

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Norway
    • Ireland
    • Turkey
    • Denmark
    • Greece
    • The Netherlands
    • Finland
    • Sweden
    • Poland